Skip to main content

Davis Stephen

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Davis Stephen as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

ACAD Acadia Pharmaceuticals Inc

CEO18 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Oct 19, 2021 (view filing)Oct 181 dayDavis StephenCEOSSale−2.96K$17.41−$51.6K−5.3%52.9K after
Jan 10, 2022 (view filing)Jan 64 daysDavis StephenCEOSSale−3.72K$23.05−$85.7K−6.0%58.7K after
Feb 25, 2022 (view filing)Feb 232 daysDavis StephenCEOSSale−3.93K$23.80−$93.5K−5.6%65.7K after
May 3, 2022 (view filing)May 21 dayDavis StephenCEOSSale−5.48K$18.18−$99.7K−6.7%75.9K after
Oct 18, 2022 (view filing)Oct 153 daysDavis StephenCEOSSale−2.80K$15.81−$44.3K−3.4%79.0K after
Jan 10, 2023 (view filing)Jan 91 dayDavis StephenCEOSSale−3.90K$17.13−$66.9K−4.4%84.6K after
Feb 27, 2023 (view filing)Feb 243 daysDavis StephenCEOSSale−3.85K$18.78−$72.3K−4.0%91.7K after
Apr 7, 2023 (view filing)Apr 61 dayDavis StephenCEOSSale−8.58K$18.16−$155.8K−7.9%100.5K after
May 2, 2023 (view filing)May 11 dayDavis StephenCEOSSale−7.81K$21.18−$165.3K−6.7%108.3K after
Jul 13, 2023 (view filing)Jul 11-122 daysDavis StephenCEOSSale−71.6K$25.04−$1.79M−66.1%36.7K after2 lots10b5-1

See all 18 trades at ACAD